Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Brian Kavanagh to Humans

This is a "connection" page, showing publications Brian Kavanagh has written about Humans.

 
Connection Strength
  
 
 
1.192
  
  1. Kavanagh BD. A Portrait of the Artist as a Younger Man. Int J Radiat Oncol Biol Phys. 2021 Dec 01; 111(5):1122.
    View in: PubMed
    Score: 0.022
  2. Fields EC, Kavanagh BD. Navigating Past the Chaos of the Radiation Oncology 2021 Match. Int J Radiat Oncol Biol Phys. 2021 10 01; 111(2):328-330.
    View in: PubMed
    Score: 0.021
  3. Kavanagh BD. The Economics of Using Locally Ablative Therapy in Oligometastatic Cancer. Semin Radiat Oncol. 2021 07; 31(3):250-252.
    View in: PubMed
    Score: 0.021
  4. Kavanagh BD, Doke K. The Virtual Visiting Professor: A Step Toward a Parasocial Common Curriculum? Int J Radiat Oncol Biol Phys. 2020 10 01; 108(2):466-469.
    View in: PubMed
    Score: 0.020
  5. Sheehan JP, Grills I, Chiang VL, Dong H, Berg A, Warnick RE, Kondziolka D, Kavanagh B. Quality of life outcomes for brain metastasis patients treated with stereotactic radiosurgery: pre-procedural predictive factors from a prospective national registry. J Neurosurg. 2019 12 01; 131(6):1848-1854.
    View in: PubMed
    Score: 0.018
  6. Rusthoven CG, Jones BL, Kavanagh BD. Medical operability and inoperability drive survival in retrospective analyses comparing surgery and SBRT for early-stage lung cancer. J Thorac Cardiovasc Surg. 2018 02; 155(2):810-811.
    View in: PubMed
    Score: 0.017
  7. Rusthoven CG, Kavanagh BD. Prophylactic Cranial Irradiation (PCI) versus Active MRI Surveillance for Small Cell Lung Cancer: The Case for Equipoise. J Thorac Oncol. 2017 12; 12(12):1746-1754.
    View in: PubMed
    Score: 0.016
  8. Rusthoven CG, Kavanagh BD. Prophylactic cranial irradiation in small-cell lung cancer. Lancet Oncol. 2017 07; 18(7):e365.
    View in: PubMed
    Score: 0.016
  9. Rusthoven CG, Palma DA, Senan S, Kavanagh BD. The Head Start Effect: Will Acute and Delayed Postoperative Mortality Lead to Improved Survival with Stereotactic Body Radiation Therapy for Operable Stage I Non-Small-Cell Lung Cancer? J Clin Oncol. 2017 05 20; 35(15):1749-1751.
    View in: PubMed
    Score: 0.016
  10. Goodman KA, Kavanagh BD. Stereotactic Body Radiotherapy for Liver Metastases. Semin Radiat Oncol. 2017 07; 27(3):240-246.
    View in: PubMed
    Score: 0.016
  11. Vinogradskiy Y, Jackson M, Schubert L, Jones B, Castillo R, Castillo E, Guerrero T, Mitchell J, Rusthoven C, Miften M, Kavanagh B. Assessing the use of 4DCT-ventilation in pre-operative surgical lung cancer evaluation. Med Phys. 2017 Jan; 44(1):200-208.
    View in: PubMed
    Score: 0.015
  12. Rusthoven CG, Koshy M, Sher DJ, Ney DE, Gaspar LE, Jones BL, Karam SD, Amini A, Ormond DR, Youssef AS, Kavanagh BD. Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis. JAMA Neurol. 2016 07 01; 73(7):821-8.
    View in: PubMed
    Score: 0.015
  13. Kavanagh BD. From the Guest Editor: New Lenses, New Visions for Radiotherapy in the Molecular-Genetic-Immunomodulator Era of Oncology. Cancer J. 2016 Jul-Aug; 22(4):245-6.
    View in: PubMed
    Score: 0.015
  14. Amini A, Rusthoven CG, Jones BL, Armstrong H, Raben D, Kavanagh BD. Survival outcomes of radiotherapy with or without androgen-deprivation therapy for patients with intermediate-risk prostate cancer using the National Cancer Data Base. Urol Oncol. 2016 Apr; 34(4):165.e1-9.
    View in: PubMed
    Score: 0.014
  15. Amini A, Jones BL, Yeh N, Rusthoven CG, Armstrong H, Kavanagh BD. Survival Outcomes of Whole-Pelvic Versus Prostate-Only Radiation Therapy for High-Risk Prostate Cancer Patients With Use of the National Cancer Data Base. Int J Radiat Oncol Biol Phys. 2015 Dec 01; 93(5):1052-63.
    View in: PubMed
    Score: 0.014
  16. Haffty BG, Beyer DC, Kavanagh BD. Radiation Oncologist Concerns About Increased Electronic Brachytherapy Use for Skin Cancer. JAMA Dermatol. 2015 Sep; 151(9):1036.
    View in: PubMed
    Score: 0.014
  17. Rusthoven CG, Carlson JA, Kavanagh BD. External Validation of the Benefit of Adjuvant Radiotherapy for Pathologic N1M0 Prostate Cancer. J Clin Oncol. 2015 Jun 10; 33(17):1987-8.
    View in: PubMed
    Score: 0.014
  18. Rusthoven CG, Carlson JA, Waxweiler TV, Dally MJ, Bar?n AE, Yeh N, Gaspar LE, Liu AK, Ney DE, Damek DM, Lillehei KO, Kavanagh BD. The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):894-902.
    View in: PubMed
    Score: 0.013
  19. Rusthoven CG, Waxweiler TV, DeWitt PE, Flaig TW, Raben D, Kavanagh BD. Gleason stratifications prognostic for survival in men receiving definitive external beam radiation therapy for localized prostate cancer. Urol Oncol. 2015 Feb; 33(2):71.e11-9.
    View in: PubMed
    Score: 0.013
  20. Kavanagh BD. Stereotactic body radiation therapy as a derivative of stereotactic radiosurgery: clinically independent but with enduring common themes. J Clin Oncol. 2014 Sep 10; 32(26):2827-31.
    View in: PubMed
    Score: 0.013
  21. Kavanagh BD, Haffty BG, Tepper JE. Radiation oncology: a snapshot in time, 2014. J Clin Oncol. 2014 Sep 10; 32(26):2825-6.
    View in: PubMed
    Score: 0.013
  22. Vinogradskiy Y, Koo PJ, Castillo R, Castillo E, Guerrero T, Gaspar LE, Miften M, Kavanagh BD. Comparison of 4-dimensional computed tomography ventilation with nuclear medicine ventilation-perfusion imaging: a clinical validation study. Int J Radiat Oncol Biol Phys. 2014 May 01; 89(1):199-205.
    View in: PubMed
    Score: 0.013
  23. Rusthoven CG, Carlson JA, Waxweiler TV, Raben D, Dewitt PE, Crawford ED, Maroni PD, Kavanagh BD. The impact of definitive local therapy for lymph node-positive prostate cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2014 Apr 01; 88(5):1064-73.
    View in: PubMed
    Score: 0.013
  24. Rusthoven CG, Carlson JA, Waxweiler TV, Yeh N, Raben D, Flaig TW, Kavanagh BD. The prognostic significance of Gleason scores in metastatic prostate cancer. Urol Oncol. 2014 Jul; 32(5):707-13.
    View in: PubMed
    Score: 0.013
  25. Kavanagh BD, Rabinovitch R, Mohideen N. Improved cosmesis in early breast cancer using conformal radiotherapy. J Clin Oncol. 2013 Dec 20; 31(36):4483-4.
    View in: PubMed
    Score: 0.012
  26. Gibbs IC, Haas-Kogan D, Terezakis S, Kavanagh BD. The subventricular zone neural progenitor cell hypothesis in glioblastoma: epiphany, Trojan Horse, or Cheshire fact? Int J Radiat Oncol Biol Phys. 2013 Jul 15; 86(4):606-8.
    View in: PubMed
    Score: 0.012
  27. Stinauer MA, Diot Q, Westerly DC, Schefter TE, Kavanagh BD. Fluorodeoxyglucose positron emission tomography response and normal tissue regeneration after stereotactic body radiotherapy to liver metastases. Int J Radiat Oncol Biol Phys. 2012 Aug 01; 83(5):e613-8.
    View in: PubMed
    Score: 0.011
  28. Guha C, Kavanagh BD. Hepatic radiation toxicity: avoidance and amelioration. Semin Radiat Oncol. 2011 Oct; 21(4):256-63.
    View in: PubMed
    Score: 0.011
  29. Schefter TE, Kavanagh BD. Radiation therapy for liver metastases. Semin Radiat Oncol. 2011 Oct; 21(4):264-70.
    View in: PubMed
    Score: 0.011
  30. Kavanagh BD, Raben D. Back to the future: a proton pro/con. Oncology (Williston Park). 2011 Jun; 25(7):657, 660, 662-3.
    View in: PubMed
    Score: 0.010
  31. Kavanagh BD, Timmerman R, Meyer JL. The expanding roles of stereotactic body radiation therapy and oligofractionation: toward a new practice of radiotherapy. Front Radiat Ther Oncol. 2011; 43:370-381.
    View in: PubMed
    Score: 0.010
  32. Kavanagh BD, Miften M, Rabinovitch RA. Advances in treatment techniques: stereotactic body radiation therapy and the spread of hypofractionation. Cancer J. 2011 May-Jun; 17(3):177-81.
    View in: PubMed
    Score: 0.010
  33. Chen C, Damek D, Gaspar LE, Waziri A, Lillehei K, Kleinschmidt-DeMasters BK, Robischon M, Stuhr K, Rusthoven KE, Kavanagh BD. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):1066-74.
    View in: PubMed
    Score: 0.010
  34. Kavanagh BD, Pan CC, Dawson LA, Das SK, Li XA, Ten Haken RK, Miften M. Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3 Suppl):S101-7.
    View in: PubMed
    Score: 0.010
  35. Rabinovitch R, Kavanagh B. Double Helix of breast cancer therapy: intertwining the Halsted and Fisher hypotheses. J Clin Oncol. 2009 May 20; 27(15):2422-3.
    View in: PubMed
    Score: 0.009
  36. Kavanagh B. Clinical experience shows that catastrophic late effects associated with ablative fractionation can be avoided by technological innovation. Semin Radiat Oncol. 2008 Oct; 18(4):223-8.
    View in: PubMed
    Score: 0.009
  37. McCammon R, Schefter TE, Gaspar LE, Zaemisch R, Gravdahl D, Kavanagh B. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):112-8.
    View in: PubMed
    Score: 0.009
  38. Kavanagh BD, Newman F. Toward a unified survival curve: in regard to Park et al. (IntJ Radiat Oncol Biol Phys 2008;70:847-852) and Krueger et al. (Int J Radiat Oncol Biol Phys 2007;69:1262-1271). Int J Radiat Oncol Biol Phys. 2008 Jul 01; 71(3):958-9.
    View in: PubMed
    Score: 0.009
  39. Kavanagh B, O'Brien S, Lee D, Hou Y, Weinberg V, Rini B, Allison JP, Small EJ, Fong L. CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion. Blood. 2008 Aug 15; 112(4):1175-83.
    View in: PubMed
    Score: 0.008
  40. Rusthoven KE, Flaig TW, Raben D, Kavanagh BD. High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials. Clin Lung Cancer. 2008 Mar; 9(2):106-11.
    View in: PubMed
    Score: 0.008
  41. Newman F, Asadi-Zeydabadi M, Durairaj VD, Ding M, Stuhr K, Kavanagh B. Visual sensations during megavoltage radiotherapy to the orbit attributable to Cherenkov radiation. Med Phys. 2008 Jan; 35(1):77-80.
    View in: PubMed
    Score: 0.008
  42. Rusthoven K, Chen C, Raben D, Kavanagh B. Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a SEER database analysis. Int J Radiat Oncol Biol Phys. 2008 May 01; 71(1):192-8.
    View in: PubMed
    Score: 0.008
  43. Kavanagh B, Ko A, Venook A, Margolin K, Zeh H, Lotze M, Schillinger B, Liu W, Lu Y, Mitsky P, Schilling M, Bercovici N, Loudovaris M, Guillermo R, Lee SM, Bender J, Mills B, Fong L. Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides. J Immunother. 2007 Oct; 30(7):762-72.
    View in: PubMed
    Score: 0.008
  44. Timmerman RD, Park C, Kavanagh BD. The North American experience with stereotactic body radiation therapy in non-small cell lung cancer. J Thorac Oncol. 2007 Jul; 2(7 Suppl 3):S101-12.
    View in: PubMed
    Score: 0.008
  45. Kavanagh BD, Kelly K, Kane M. The promise of stereotactic body radiation therapy in a new era of oncology. Front Radiat Ther Oncol. 2007; 40:340-351.
    View in: PubMed
    Score: 0.008
  46. Kavanagh BD, Scheftera TE, Wers?ll PJ. Liver, renal, and retroperitoneal tumors: stereotactic radiotherapy. Front Radiat Ther Oncol. 2007; 40:415-426.
    View in: PubMed
    Score: 0.008
  47. Crawford ED, Kavanagh BD. The role of alpha-blockers in the management of lower urinary tract symptoms in prostate cancer patients treated with radiation therapy. Am J Clin Oncol. 2006 Oct; 29(5):517-23.
    View in: PubMed
    Score: 0.008
  48. Kavanagh BD, Raben D. Toward a unified target theory in oncology. Future Oncol. 2006 Aug; 2(4):435-6.
    View in: PubMed
    Score: 0.007
  49. Kavanagh BD, Ding M, Schefter TE, Stuhr K, Newman FA. The dosimetric effect of inhomogeneity correction in dynamic conformal arc stereotactic body radiation therapy for lung tumors. J Appl Clin Med Phys. 2006 May 25; 7(2):58-63.
    View in: PubMed
    Score: 0.007
  50. Kavanagh BD, McGarry RC, Timmerman RD. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. Semin Radiat Oncol. 2006 Apr; 16(2):77-84.
    View in: PubMed
    Score: 0.007
  51. Poznanovic SA, Cass SP, Kavanagh BD. Short-term tumor control and acute toxicity after stereotactic radiosurgery for glomus jugulare tumors. Otolaryngol Head Neck Surg. 2006 Mar; 134(3):437-42.
    View in: PubMed
    Score: 0.007
  52. Kavanagh BD, Timmerman RD. Stereotactic radiosurgery and stereotactic body radiation therapy: an overview of technical considerations and clinical applications. Hematol Oncol Clin North Am. 2006 Feb; 20(1):87-95.
    View in: PubMed
    Score: 0.007
  53. Kavanagh BD, Schefter TE, Cardenes HR, Stieber VW, Raben D, Timmerman RD, McCarter MD, Burri S, Nedzi LA, Sawyer TE, Gaspar LE. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol. 2006; 45(7):848-55.
    View in: PubMed
    Score: 0.007
  54. Timmerman RD, Kavanagh BD. Stereotactic body radiation therapy. Curr Probl Cancer. 2005 May-Jun; 29(3):120-57.
    View in: PubMed
    Score: 0.007
  55. Bayat F, Miller B, Park Y, Yu Z, Alexeev T, Thomas D, Stuhr K, Kavanagh B, Miften M, Altunbas C. 2D antiscatter grid and scatter sampling based CBCT method for online dose calculations during CBCT guided radiation therapy of pelvis. Med Phys. 2024 Apr; 51(4):3053-3066.
    View in: PubMed
    Score: 0.006
  56. Kavanagh BD. The emperor's new isodose curves. Med Phys. 2003 Sep; 30(9):2559-60.
    View in: PubMed
    Score: 0.006
  57. Rusthoven CG, Staley AW, Gao D, Yomo S, Bernhardt D, Wandrey N, El Shafie R, Kraemer A, Padilla O, Chiang V, Faramand AM, Palmer JD, Zacharia BE, Wegner RE, Hattangadi-Gluth JA, Levy A, Bernstein K, Mathieu D, Cagney DN, Chan MD, Grills IS, Braunstein S, Lee CC, Sheehan JP, Kluwe C, Patel S, Halasz LM, Andratschke N, Deibert CP, Verma V, Trifiletti DM, Cifarelli CP, Debus J, Combs SE, Sato Y, Higuchi Y, Aoyagi K, Brown PD, Alami V, Niranjan A, Lunsford LD, Kondziolka D, Camidge DR, Kavanagh BD, Robin TP, Serizawa T, Yamamoto M. Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE). J Natl Cancer Inst. 2023 08 08; 115(8):926-936.
    View in: PubMed
    Score: 0.006
  58. Ghassemi N, Castillo R, Castillo E, Jones BL, Miften M, Kavanagh B, Werner-Wasik M, Miller R, Barta JA, Grills I, Leiby BE, Guerrero T, Rusthoven CG, Vinogradskiy Y. Evaluation of variables predicting PFT changes for lung cancer patients treated on a prospective 4DCT-ventilation functional avoidance clinical trial. Radiother Oncol. 2023 10; 187:109821.
    View in: PubMed
    Score: 0.006
  59. Kavanagh BD, Timmerman RD, Benedict SH, Wu Q, Schefter TE, Stuhr K, McCourt S, Newman F, Cardinale RM, Gaspar LF. How should we describe the radioblologic effect of extracranial stereotactic radlosurgery: equivalent uniform dose or tumor control probability? Med Phys. 2003 Mar; 30(3):321-4.
    View in: PubMed
    Score: 0.006
  60. Langston J, Patil T, Ross Camidge D, Bunn PA, Schenk EL, Pacheco JM, Jurica J, Waxweiler TV, Kavanagh BD, Rusthoven CG. CNS Downstaging: An Emerging Treatment Paradigm for Extensive Brain Metastases in Oncogene-Addicted Lung Cancer. Lung Cancer. 2023 04; 178:103-107.
    View in: PubMed
    Score: 0.006
  61. Jeans EB, Brower JV, Burmeister JW, Deville C, Fields E, Kavanagh BD, Suh JH, Tekian A, Vapiwala N, Zeman EM, Golden DW. Development of a United States Radiation Oncology Curricular Framework: A Stakeholder Delphi Consensus. Int J Radiat Oncol Biol Phys. 2023 04 01; 115(5):1030-1040.
    View in: PubMed
    Score: 0.006
  62. Milano MT, Soltys SG, Marks LB, Heron DE, Yorke E, Grimm J, Jackson A, Mihai A, Timmerman RD, Xue J, Kavanagh BD, Redmond KJ. The Art of Radiation Therapy: The Necessary Risk of Radiation Necrosis for Durable Control of Brain Metastases. Int J Radiat Oncol Biol Phys. 2023 02 01; 115(2):294-296.
    View in: PubMed
    Score: 0.006
  63. Kavanagh BD, Schefter TE, Wu Q, Tong S, Newman F, Arnfield M, Benedict SH, McCourt S, Mohan R. Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. Semin Radiat Oncol. 2002 Jul; 12(3):260-71.
    View in: PubMed
    Score: 0.006
  64. Liu J, Chen YJ, Williams TM, Fields E, Kavanagh B, Shah C, Royce T, Ladbury C, Amini A, Glaser S. Evaluation of Radiation Oncologist and Trainee Opinions on Residency Expansion, Possible Actions, and Training Program Accreditation Changes in the United States. Int J Radiat Oncol Biol Phys. 2022 09 01; 114(1):16-20.
    View in: PubMed
    Score: 0.006
  65. Kavanagh BD, Secomb TW, Hsu R, Lin PS, Venitz J, Dewhirst MW. A theoretical model for the effects of reduced hemoglobin-oxygen affinity on tumor oxygenation. Int J Radiat Oncol Biol Phys. 2002 May 01; 53(1):172-9.
    View in: PubMed
    Score: 0.006
  66. Das IJ, Dawes SL, Dominello MM, Kavanagh B, Miyamoto CT, Pawlicki T, Santanam L, Vinogradskiy Y, Yeung AR. Quality and Safety Considerations in Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: An ASTRO Safety White Paper Update. Pract Radiat Oncol. 2022 Jul-Aug; 12(4):e253-e268.
    View in: PubMed
    Score: 0.006
  67. Vinogradskiy Y, Castillo R, Castillo E, Schubert L, Jones BL, Faught A, Gaspar LE, Kwak J, Bowles DW, Waxweiler T, Dougherty JM, Gao D, Stevens C, Miften M, Kavanagh B, Grills I, Rusthoven CG, Guerrero T. Results of a Multi-Institutional Phase 2 Clinical Trial for 4DCT-Ventilation Functional Avoidance Thoracic Radiation Therapy. Int J Radiat Oncol Biol Phys. 2022 03 15; 112(4):986-995.
    View in: PubMed
    Score: 0.005
  68. Kavanagh BD, Fischer BA, Segreti EM, Wheelock JB, Boardman C, Roseff SD, Cardinale RM, Benedict SH, Goram AL. Cost analysis of erythropoietin versus blood transfusions for cervical cancer patients receiving chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2001 Oct 01; 51(2):435-41.
    View in: PubMed
    Score: 0.005
  69. Hubbard A, Mantz C, Mohideen N, Hartsell W, Thaker NG, Orio P, Yashar C, Kavadi V, Kavanagh B, Adler D. Radiation Oncology's Place in Payment Reform: ASTRO Advocates for a Place at the Table. JCO Oncol Pract. 2021 12; 17(12):777-781.
    View in: PubMed
    Score: 0.005
  70. Tsui DCC, Kavanagh BD, Honce JM, Rossi C, Patil T, Camidge DR. Central Nervous System Response to Selpercartinib in Patient With RET-rearranged Non-small Cell Lung Cancer After Developing Leptomeningeal Disease on Pralsetinib. Clin Lung Cancer. 2022 01; 23(1):e5-e8.
    View in: PubMed
    Score: 0.005
  71. Grimm J, Marks LB, Jackson A, Kavanagh BD, Xue J, Yorke E. High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): An Overview. Int J Radiat Oncol Biol Phys. 2021 05 01; 110(1):1-10.
    View in: PubMed
    Score: 0.005
  72. Kavanagh BD, Segreti EM, Koo D, Amir C, Arthur D, Wheelock J, Cardinale RM, Schmidt-Ullrich RK. Long-term local control and survival after concomitant boost accelerated radiotherapy for locally advanced cervix cancer. Am J Clin Oncol. 2001 Apr; 24(2):113-9.
    View in: PubMed
    Score: 0.005
  73. Kavanagh BD, Khandelwal SR, Schmidt-Ullrich RK, Roberts JD, Shaw EG, Pearlman AD, Venitz J, Dusenbery KE, Abraham DJ, Gerber MJ. A phase I study of RSR13, a radiation-enhancing hemoglobin modifier: tolerance of repeated intravenous doses and correlation of pharmacokinetics with pharmacodynamics. Int J Radiat Oncol Biol Phys. 2001 Mar 15; 49(4):1133-9.
    View in: PubMed
    Score: 0.005
  74. Goodman CR, Sim AJ, Jeans EB, Anderson JD, Dooley S, Agarwal A, Tye K, Albert A, Gillespie EF, Tendulkar RD, Fuller CD, Kavanagh BD, Campbell SR. No Longer a Match: Trends in Radiation Oncology National Resident Matching Program (NRMP) Data from 2010-2020 and Comparison Across Specialties. Int J Radiat Oncol Biol Phys. 2021 06 01; 110(2):278-287.
    View in: PubMed
    Score: 0.005
  75. Novak J, Cui Y, Frankel P, Sedrak MS, Glaser S, Li R, Motwani S, Kavanagh B, Amini A. Growth of the Social #RadOnc Network on Twitter. Pract Radiat Oncol. 2021 May-Jun; 11(3):e263-e266.
    View in: PubMed
    Score: 0.005
  76. Boxley PJ, Smith DE, Gao D, Kessler ER, Echalier B, Bernard B, Ormond DR, Lam ET, Kavanagh BD, Flaig TW. Prostate Cancer Central Nervous System Metastasis in a Contemporary Cohort. Clin Genitourin Cancer. 2021 06; 19(3):217-222.e1.
    View in: PubMed
    Score: 0.005
  77. Thomas DH, Schubert LK, Vinogradskiy Y, Nath S, Kavanagh B, Miften M, Jones B. Technical Note: Deep Learning approach for automatic detection and identification of patient positioning devices for radiation therapy. Med Phys. 2020 Oct; 47(10):5061-5069.
    View in: PubMed
    Score: 0.005
  78. Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB 2nd, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D. Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement. Int J Radiat Oncol Biol Phys. 2020 07 15; 107(4):631-640.
    View in: PubMed
    Score: 0.005
  79. Cardinale RM, Kavanagh BD. Conformal radiotherapy: what is it and why does it matter? Surg Oncol Clin N Am. 2000 Jul; 9(3):415-34, vii.
    View in: PubMed
    Score: 0.005
  80. Rusthoven CG, Yamamoto M, Bernhardt D, Smith DE, Gao D, Serizawa T, Yomo S, Aiyama H, Higuchi Y, Shuto T, Akabane A, Sato Y, Niranjan A, Faramand AM, Lunsford LD, McInerney J, Tuanquin LC, Zacharia BE, Chiang V, Singh C, Yu JB, Braunstein S, Mathieu D, Touchette CJ, Lee CC, Yang HC, Aizer AA, Cagney DN, Chan MD, Kondziolka D, Bernstein K, Silverman JS, Grills IS, Siddiqui ZA, Yuan JC, Sheehan JP, Cordeiro D, Nosaki K, Seto T, Deibert CP, Verma V, Day S, Halasz LM, Warnick RE, Trifiletti DM, Palmer JD, Attia A, Li B, Cifarelli CP, Brown PD, Vargo JA, Combs SE, Kessel KA, Rieken S, Patel S, Guckenberger M, Andratschke N, Kavanagh BD, Robin TP. Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study. JAMA Oncol. 2020 07 01; 6(7):1028-1037.
    View in: PubMed
    Score: 0.005
  81. Kavanagh BD, Zwicker RD, Segreti EM, Lindquist LA, Fulcher AS, Hundley GM, Spindler JA, Cardinale RM. Gynecologic brachytherapy: digital fluoroscopy for placement verification and treatment planning. Radiology. 2000 Jun; 215(3):900-3.
    View in: PubMed
    Score: 0.005
  82. Thomas DH, Miller B, Rabinovitch R, Milgrom S, Kavanagh B, Diot Q, Miften M, Schubert LK. Integration of automation into an existing clinical workflow to improve efficiency and reduce errors in the manual treatment planning process for total body irradiation (TBI). J Appl Clin Med Phys. 2020 Jul; 21(7):100-106.
    View in: PubMed
    Score: 0.005
  83. Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB 2nd, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. Radiother Oncol. 2020 05; 146:223-229.
    View in: PubMed
    Score: 0.005
  84. Kavanagh BD, Campbell RL, Patterson JW, O'Neill RL, Cardinale RM, Kaugars GE. Desmoplastic malignant melanoma of the palatal alveolar mucosa: sustained disease-free survival after surgery and postoperative radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Apr; 89(4):465-70.
    View in: PubMed
    Score: 0.005
  85. Vinogradskiy Y, Diot Q, Jones B, Castillo R, Castillo E, Kwak J, Bowles D, Grills I, Myziuk N, Guerrero T, Stevens C, Schefter T, Gaspar LE, Kavanagh B, Miften M, Rusthoven C. Evaluating Positron Emission Tomography-Based Functional Imaging Changes in the Heart After Chemo-Radiation for Patients With Lung Cancer. Int J Radiat Oncol Biol Phys. 2020 04 01; 106(5):1063-1070.
    View in: PubMed
    Score: 0.005
  86. Fulcher AS, O'Sullivan SG, Segreti EM, Kavanagh BD. Recurrent cervical carcinoma: typical and atypical manifestations. Radiographics. 1999 Oct; 19 Spec No:S103-16; quiz S264-5.
    View in: PubMed
    Score: 0.005
  87. Wong DT, Gomez M, McGuire GP, Kavanagh B. Utilization of intensive care unit days in a Canadian medical-surgical intensive care unit. Crit Care Med. 1999 Jul; 27(7):1319-24.
    View in: PubMed
    Score: 0.005
  88. Ladbury CJ, Rusthoven CG, Camidge DR, Kavanagh BD, Nath SK. Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation Therapy. Int J Radiat Oncol Biol Phys. 2019 10 01; 105(2):346-355.
    View in: PubMed
    Score: 0.005
  89. Gomez DR, Tang C, Zhang J, Blumenschein GR, Hernandez M, Lee JJ, Ye R, Palma DA, Louie AV, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Welsh JW, Gibbons DL, Karam JA, Kavanagh BD, Tsao AS, Sepesi B, Swisher SG, Heymach JV. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study. J Clin Oncol. 2019 06 20; 37(18):1558-1565.
    View in: PubMed
    Score: 0.005
  90. Stumpf PK, Cittelly DM, Robin TP, Carlson JA, Stuhr KA, Contreras-Zarate MJ, Lai S, Ormond DR, Rusthoven CG, Gaspar LE, Rabinovitch R, Kavanagh BD, Liu A, Diamond JR, Kabos P, Fisher CM. Combination of Trastuzumab Emtansine and Stereotactic Radiosurgery Results in High Rates of Clinically Significant Radionecrosis and Dysregulation of Aquaporin-4. Clin Cancer Res. 2019 07 01; 25(13):3946-3953.
    View in: PubMed
    Score: 0.004
  91. Weiss J, Kavanagh B, Deal A, Villaruz L, Stevenson J, Camidge R, Borghaei H, West J, Kirpalani P, Morris D, Lee C, Pecot CV, Zagar T, Stinchcombe T, Pennell N. Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinib. Cancer Treat Res Commun. 2019; 19:100126.
    View in: PubMed
    Score: 0.004
  92. Pacheco JM, Gao D, Smith D, Purcell T, Hancock M, Bunn P, Robin T, Liu A, Karam S, Gaspar L, Kavanagh B, Rusthoven C, Aisner D, Doebele R, Camidge DR. Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non-Small Cell Lung Cancer. J Thorac Oncol. 2019 04; 14(4):691-700.
    View in: PubMed
    Score: 0.004
  93. Kavanagh BD, Kachnic LA, Amaker BH, Broaddus WC, Cardinale RM, Manning MA, Ginder G, Pizzuti T. A 54-year-old woman with recurrent headaches and seizures. Oncology (Williston Park). 1998 Nov; 12(11):1669-73.
    View in: PubMed
    Score: 0.004
  94. Vinogradskiy Y, Rusthoven CG, Schubert L, Jones B, Faught A, Castillo R, Castillo E, Gaspar LE, Kwak J, Waxweiler T, Dougherty M, Gao D, Stevens C, Miften M, Kavanagh B, Guerrero T, Grills I. Interim Analysis of a Two-Institution, Prospective Clinical Trial of 4DCT-Ventilation-based Functional Avoidance Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018 11 15; 102(4):1357-1365.
    View in: PubMed
    Score: 0.004
  95. Robin TP, Breeze RE, Smith DE, Rusthoven CG, Lewis KD, Gonzalez R, Brill A, Saiki R, Stuhr K, Gaspar LE, Karam SD, Raben D, Kavanagh BD, Nath SK, Liu AK. Immune checkpoint inhibitors and radiosurgery for newly diagnosed melanoma brain metastases. J Neurooncol. 2018 Oct; 140(1):55-62.
    View in: PubMed
    Score: 0.004
  96. Kavanagh BD, Dent P, Schmidt-Ullrich RK, Chen P, Mikkelsen RB. Calcium-dependent stimulation of mitogen-activated protein kinase activity in A431 cells by low doses of ionizing radiation. Radiat Res. 1998 Jun; 149(6):579-87.
    View in: PubMed
    Score: 0.004
  97. Amini A, Yeh N, Jones BL, Bedrick E, Vinogradskiy Y, Rusthoven CG, Amini A, Purcell WT, Karam SD, Kavanagh BD, Guntupalli SR, Fisher CM. Perioperative Mortality in Nonelderly Adult Patients With Cancer: A Population-based Study Evaluating Health Care Disparities in the United States According to Insurance Status. Am J Clin Oncol. 2018 05; 41(5):476-484.
    View in: PubMed
    Score: 0.004
  98. Robin TP, Jones BL, Amini A, Koshy M, Gaspar LE, Liu AK, Nath SK, Kavanagh BD, Camidge DR, Rusthoven CG. Radiosurgery alone is associated with favorable outcomes for brain metastases from small-cell lung cancer. Lung Cancer. 2018 06; 120:88-90.
    View in: PubMed
    Score: 0.004
  99. Stokes WA, Bronsert MR, Meguid RA, Blum MG, Jones BL, Koshy M, Sher DJ, Louie AV, Palma DA, Senan S, Gaspar LE, Kavanagh BD, Rusthoven CG. Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer. J Clin Oncol. 2018 03 01; 36(7):642-651.
    View in: PubMed
    Score: 0.004
  100. Miften M, Vinogradskiy Y, Moiseenko V, Grimm J, Yorke E, Jackson A, Tom? WA, Ten Haken RK, Ohri N, M?ndez Romero A, Goodman KA, Marks LB, Kavanagh B, Dawson LA. Radiation Dose-Volume Effects for Liver SBRT. Int J Radiat Oncol Biol Phys. 2021 05 01; 110(1):196-205.
    View in: PubMed
    Score: 0.004
  101. Robin TP, Camidge DR, Stuhr K, Nath SK, Breeze RE, Pacheco JM, Liu AK, Gaspar LE, Purcell WT, Doebele RC, Kavanagh BD, Rusthoven CG. Excellent Outcomes with Radiosurgery for Multiple?Brain Metastases in ALK and EGFR Driven?Non-Small Cell Lung Cancer. J Thorac Oncol. 2018 05; 13(5):715-720.
    View in: PubMed
    Score: 0.004
  102. Jaffee EM, Dang CV, Agus DB, Alexander BM, Anderson KC, Ashworth A, Barker AD, Bastani R, Bhatia S, Bluestone JA, Brawley O, Butte AJ, Coit DG, Davidson NE, Davis M, DePinho RA, Diasio RB, Draetta G, Frazier AL, Futreal A, Gambhir SS, Ganz PA, Garraway L, Gerson S, Gupta S, Heath J, Hoffman RI, Hudis C, Hughes-Halbert C, Ibrahim R, Jadvar H, Kavanagh B, Kittles R, Le QT, Lippman SM, Mankoff D, Mardis ER, Mayer DK, McMasters K, Meropol NJ, Mitchell B, Naredi P, Ornish D, Pawlik TM, Peppercorn J, Pomper MG, Raghavan D, Ritchie C, Schwarz SW, Sullivan R, Wahl R, Wolchok JD, Wong SL, Yung A. Future cancer research priorities in the USA: a Lancet Oncology Commission. Lancet Oncol. 2017 11; 18(11):e653-e706.
    View in: PubMed
    Score: 0.004
  103. Sheehan J, Suh JH, Kavanagh B, Xu Z, Ren L, Sheehan K, Lunsford LD. Training Neurosurgery and Radiation Oncology Residents in Stereotactic Radiosurgery: Assessment Gathered from Participants in AANS and ASTRO Training Course. World Neurosurg. 2018 Jan; 109:e669-e675.
    View in: PubMed
    Score: 0.004
  104. Chen AB, Li L, Cronin AM, Brooks GA, Kavanagh BD, Schrag D. Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter? Health Serv Res. 2018 08; 53 Suppl 1:3227-3244.
    View in: PubMed
    Score: 0.004
  105. Trifiletti DM, Sheehan JP, Grover S, Dutta SW, Rusthoven CG, Kavanagh BD, Sahgal A, Showalter TN. National trends in radiotherapy for brain metastases at time of diagnosis of non-small cell lung cancer. J Clin Neurosci. 2017 Nov; 45:48-53.
    View in: PubMed
    Score: 0.004
  106. Stokes WA, Kavanagh BD, Raben D, Pugh TJ. Implementation of hypofractionated prostate radiation therapy in the United States: A National Cancer Database analysis. Pract Radiat Oncol. 2017 Jul - Aug; 7(4):270-278.
    View in: PubMed
    Score: 0.004
  107. Altunbas C, Kavanagh B, Alexeev T, Miften M. Transmission characteristics of a two dimensional antiscatter grid prototype for CBCT. Med Phys. 2017 Aug; 44(8):3952-3964.
    View in: PubMed
    Score: 0.004
  108. Kavanagh BD, Gieschen HL, Schmidt-Ullrich RK, Arthur D, Zwicker R, Kaufman N, Goplerud DR, Segreti EM, West RJ. A pilot study of concomitant boost accelerated superfractionated radiotherapy for stage III cancer of the uterine cervix. Int J Radiat Oncol Biol Phys. 1997 Jun 01; 38(3):561-8.
    View in: PubMed
    Score: 0.004
  109. Waxweiler T, Schubert L, Diot Q, Faught A, Stuhr K, Castillo R, Castillo E, Guerrero T, Rusthoven C, Gaspar L, Kavanagh B, Miften M, Vinogradskiy Y. A complete 4DCT-ventilation functional avoidance virtual trial: Developing strategies for prospective clinical trials. J Appl Clin Med Phys. 2017 May; 18(3):144-152.
    View in: PubMed
    Score: 0.004
  110. Jackson MW, Palma DA, Camidge DR, Jones BL, Robin TP, Sher DJ, Koshy M, Kavanagh BD, Gaspar LE, Rusthoven CG. The Impact of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma. J Thorac Oncol. 2017 04; 12(4):734-744.
    View in: PubMed
    Score: 0.004
  111. Magnuson WJ, Lester-Coll NH, Wu AJ, Yang TJ, Lockney NA, Gerber NK, Beal K, Amini A, Patil T, Kavanagh BD, Camidge DR, Braunstein SE, Boreta LC, Balasubramanian SK, Ahluwalia MS, Rana NG, Attia A, Gettinger SN, Contessa JN, Yu JB, Chiang VL. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Na?ve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis. J Clin Oncol. 2017 Apr 01; 35(10):1070-1077.
    View in: PubMed
    Score: 0.004
  112. Rusthoven CG, Jones BL, Kavanagh BD, Pugh TJ. Reply to J.B. Aragon-Ching and D. Dalela et al. J Clin Oncol. 2017 03 10; 35(8):916-917.
    View in: PubMed
    Score: 0.004
  113. Gomez DR, Blumenschein GR, Lee JJ, Hernandez M, Ye R, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Gibbons DL, Karam JA, Kavanagh BD, Tang C, Komaki R, Louie AV, Palma DA, Tsao AS, Sepesi B, William WN, Zhang J, Shi Q, Wang XS, Swisher SG, Heymach JV. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol. 2016 Dec; 17(12):1672-1682.
    View in: PubMed
    Score: 0.004
  114. Vinogradskiy Y, Schubert L, Diot Q, Waxweiller T, Koo P, Castillo R, Castillo E, Guerrero T, Rusthoven C, Gaspar L, Kavanagh B, Miften M. Regional Lung Function Profiles of Stage I and III Lung Cancer Patients: An Evaluation for Functional Avoidance Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 07 15; 95(4):1273-80.
    View in: PubMed
    Score: 0.004
  115. Benedict SH, Hoffman K, Martel MK, Abernethy AP, Asher AL, Capala J, Chen RC, Chera B, Couch J, Deye J, Efstathiou JA, Ford E, Fraass BA, Gabriel PE, Huser V, Kavanagh BD, Khuntia D, Marks LB, Mayo C, McNutt T, Miller RS, Moore KL, Prior F, Roelofs E, Rosenstein BS, Sloan J, Theriault A, Vikram B. Overview of the American Society for Radiation Oncology-National Institutes of Health-American Association of Physicists in Medicine Workshop 2015: Exploring Opportunities for Radiation Oncology in the Era of Big Data. Int J Radiat Oncol Biol Phys. 2016 07 01; 95(3):873-879.
    View in: PubMed
    Score: 0.004
  116. Kim DN, Straka C, Cho LC, Lotan Y, Yan J, Kavanagh B, Raben D, Cooley S, Brindle J, Xie XJ, Pistenmaa D, Timmerman R. Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1/2 trial. Pract Radiat Oncol. 2017 Jan - Feb; 7(1):e43-e49.
    View in: PubMed
    Score: 0.004
  117. Rusthoven CG, Jones BL, Flaig TW, Crawford ED, Koshy M, Sher DJ, Mahmood U, Chen RC, Chapin BF, Kavanagh BD, Pugh TJ. Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer. J Clin Oncol. 2016 08 20; 34(24):2835-42.
    View in: PubMed
    Score: 0.004
  118. Amini A, Jones BL, Yeh N, Guntupalli SR, Kavanagh BD, Karam SD, Fisher CM. Disparities in disease presentation in the four screenable cancers according to health insurance status. Public Health. 2016 Sep; 138:50-6.
    View in: PubMed
    Score: 0.004
  119. Deschamps A, Hall R, Grocott H, Mazer CD, Choi PT, Turgeon AF, de Medicis E, Bussi?res JS, Hudson C, Syed S, Seal D, Herd S, Lambert J, Denault A, Deschamps A, Mutch A, Turgeon A, Denault A, Todd A, Jerath A, Fayad A, Finnegan B, Kent B, Kennedy B, Cuthbertson BH, Kavanagh B, Warriner B, MacAdams C, Lehmann C, Fudorow C, Hudson C, McCartney C, McIsaac D, Dubois D, Campbell D, Mazer D, Neilpovitz D, Rosen D, Cheng D, Drapeau D, Dillane D, Tran D, Mckeen D, Wijeysundera D, Jacobsohn E, Couture E, de Medicis E, Alam F, Abdallah F, Ralley FE, Chung F, Lellouche F, Dobson G, Germain G, Djaiani G, Gilron I, Hare G, Bryson G, Clarke H, McDonald H, Roman-Smith H, Grocott H, Yang H, Douketis J, Paul J, Beaubien J, Bussi?res J, Pridham J, Armstrong JN, Parlow J, Murkin J, Gamble J, Duttchen K, Karkouti K, Turner K, Baghirzada L, Szabo L, Lalu M, Wasowicz M, Bautista M, Jacka M, Murphy M, Schmidt M, Verret M, Perrault MA, Beaudet N, Buckley N, Choi P, MacDougall P, Jones P, Drolet P, Beaulieu P, Taneja R, Martin R, Hall R, George R, Chun R, McMullen S, Beattie S, Sampson S, Choi S, Kowalski S, McCluskey S, Syed S, Boet S, Ramsay T, Saha T, Mutter T, Chowdhury T, Uppal V, Mckay W. Cerebral Oximetry Monitoring to Maintain Normal Cerebral Oxygen Saturation during High-risk Cardiac Surgery: A Randomized Controlled Feasibility Trial. Anesthesiology. 2016 Apr; 124(4):826-36.
    View in: PubMed
    Score: 0.004
  120. Hannan R, Tumati V, Xie XJ, Cho LC, Kavanagh BD, Brindle J, Raben D, Nanda A, Cooley S, Kim DWN, Pistenmaa D, Lotan Y, Timmerman R. Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial. Eur J Cancer. 2016 05; 59:142-151.
    View in: PubMed
    Score: 0.004
  121. Zhao J, Yorke ED, Li L, Kavanagh BD, Li XA, Das S, Miften M, Rimner A, Campbell J, Xue J, Jackson A, Grimm J, Milano MT, Spring Kong FM. Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies. Int J Radiat Oncol Biol Phys. 2016 Aug 01; 95(5):1357-1366.
    View in: PubMed
    Score: 0.004
  122. Amini A, Jones BL, Jackson MW, Rusthoven CG, Maroni P, Kavanagh BD, Raben D. Survival outcomes of combined external beam radiotherapy and brachytherapy vs. brachytherapy alone for intermediate-risk prostate cancer patients using the National Cancer Data Base. Brachytherapy. 2016 Mar-Apr; 15(2):136-46.
    View in: PubMed
    Score: 0.004
  123. Kavanagh BD, Lin PS, Chen P, Schmidt-Ullrich RK. Radiation-induced enhanced proliferation of human squamous cancer cells in vitro: a release from inhibition by epidermal growth factor. Clin Cancer Res. 1995 Dec; 1(12):1557-62.
    View in: PubMed
    Score: 0.004
  124. Amini A, Jones B, Jackson MW, Yeh N, Waxweiler TV, Maroni P, Kavanagh BD, Raben D. Survival Outcomes of Dose-Escalated External Beam Radiotherapy versus Combined Brachytherapy for Intermediate and High Risk Prostate Cancer Using the National Cancer Data Base. J Urol. 2016 May; 195(5):1453-1458.
    View in: PubMed
    Score: 0.004
  125. Chen RC, Gabriel PE, Kavanagh BD, McNutt TR. How Will Big Data Impact Clinical Decision Making and Precision Medicine in Radiation Therapy? Int J Radiat Oncol Biol Phys. 2016 07 01; 95(3):880-884.
    View in: PubMed
    Score: 0.004
  126. Diot Q, Kavanagh B, Vinogradskiy Y, Garg K, Gaspar L, Miften M. Lung deformations and radiation-induced regional lung collapse in patients treated with stereotactic body radiation therapy. Med Phys. 2015 Nov; 42(11):6477-87.
    View in: PubMed
    Score: 0.004
  127. Altoos B, Amini A, Yacoub M, Bourlon MT, Kessler EE, Flaig TW, Fisher CM, Kavanagh BD, Lam ET, Karam SD. Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT). Radiat Oncol. 2015 Oct 28; 10:218.
    View in: PubMed
    Score: 0.004
  128. Johung KL, Yeh N, Desai NB, Williams TM, Lautenschlaeger T, Arvold ND, Ning MS, Attia A, Lovly CM, Goldberg S, Beal K, Yu JB, Kavanagh BD, Chiang VL, Camidge DR, Contessa JN. Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis. J Clin Oncol. 2016 Jan 10; 34(2):123-9.
    View in: PubMed
    Score: 0.004
  129. Sheehan JP, Kavanagh BD, Asher A, Harbaugh RE. Inception of a national multidisciplinary registry for stereotactic radiosurgery. J Neurosurg. 2016 Jan; 124(1):155-62.
    View in: PubMed
    Score: 0.003
  130. Chetty IJ, Martel MK, Jaffray DA, Benedict SH, Hahn SM, Berbeco R, Deye J, Jeraj R, Kavanagh B, Krishnan S, Lee N, Low DA, Mankoff D, Marks LB, Ollendorf D, Paganetti H, Ross B, Siochi RA, Timmerman RD, Wong JW. Technology for Innovation in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2015 Nov 01; 93(3):485-92.
    View in: PubMed
    Score: 0.003
  131. Amini A, Altoos B, Bourlon MT, Bedrick E, Bhatia S, Kessler ER, Flaig TW, Fisher CM, Kavanagh BD, Lam ET, Karam SD. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant? Pract Radiat Oncol. 2015 Nov-Dec; 5(6):e589-e596.
    View in: PubMed
    Score: 0.003
  132. Carlson JA, Reddy K, Gaspar LE, Ney D, Kavanagh BD, Damek D, Lillehei K, Chen C. Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials. J Neurooncol. 2015 Jun; 123(2):251-7.
    View in: PubMed
    Score: 0.003
  133. Brennan D, Schubert L, Diot Q, Castillo R, Castillo E, Guerrero T, Martel MK, Linderman D, Gaspar LE, Miften M, Kavanagh BD, Vinogradskiy Y. Clinical validation of 4-dimensional computed tomography ventilation with pulmonary function test data. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):423-9.
    View in: PubMed
    Score: 0.003
  134. Ney DE, Carlson JA, Damek DM, Gaspar LE, Kavanagh BD, Kleinschmidt-DeMasters BK, Waziri AE, Lillehei KO, Reddy K, Chen C. Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma. J Neurooncol. 2015 Mar; 122(1):135-43.
    View in: PubMed
    Score: 0.003
  135. Hahn C, Kavanagh B, Bhatnagar A, Jacobson G, Lutz S, Patton C, Potters L, Steinberg M. Choosing wisely: the American Society for Radiation Oncology's top 5 list. Pract Radiat Oncol. 2014 Nov-Dec; 4(6):349-55.
    View in: PubMed
    Score: 0.003
  136. Bourlon MT, Amini A, Kavanagh BD, Flaig TW. Pancreatic metastases from renal cell carcinoma treated with stereotactic body radiation therapy. Oncology (Williston Park). 2014 Nov; 28(11):1008-12.
    View in: PubMed
    Score: 0.003
  137. Iyengar P, Kavanagh BD, Wardak Z, Smith I, Ahn C, Gerber DE, Dowell J, Hughes R, Abdulrahman R, Camidge DR, Gaspar LE, Doebele RC, Bunn PA, Choy H, Timmerman R. Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer. J Clin Oncol. 2014 Dec 01; 32(34):3824-30.
    View in: PubMed
    Score: 0.003
  138. Kavanagh BD, Bentel GC, Montana GS. Soft tissue complication rates after low dose rate brachytherapy using customized perineal templates. Int J Radiat Oncol Biol Phys. 1994 Sep 30; 30(2):508.
    View in: PubMed
    Score: 0.003
  139. Amini A, Yeh N, Gaspar LE, Kavanagh B, Karam SD. Stereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review. Radiat Oncol. 2014 Sep 19; 9:210.
    View in: PubMed
    Score: 0.003
  140. Carlson JA, Nooruddin Z, Rusthoven C, Elias A, Borges VF, Diamond JR, Kavanagh B, Kabos P. Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema. Neuro Oncol. 2014 Jul; 16(7):1006-9.
    View in: PubMed
    Score: 0.003
  141. Kim DW, Cho LC, Straka C, Christie A, Lotan Y, Pistenmaa D, Kavanagh BD, Nanda A, Kueplian P, Brindle J, Cooley S, Perkins A, Raben D, Xie XJ, Timmerman RD. Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2014 Jul 01; 89(3):509-17.
    View in: PubMed
    Score: 0.003
  142. Diot Q, Marks LB, Bentzen SM, Senan S, Kavanagh BD, Lawrence MV, Miften M, Palma DA. Comparison of radiation-induced normal lung tissue density changes for patients from multiple institutions receiving conventional or hypofractionated treatments. Int J Radiat Oncol Biol Phys. 2014 Jul 01; 89(3):626-32.
    View in: PubMed
    Score: 0.003
  143. Reddy K, Gaspar LE, Kavanagh BD, Chen C. Hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy may alter the patterns of failure in patients with glioblastoma multiforme. J Med Imaging Radiat Oncol. 2014 Dec; 58(6):714-21.
    View in: PubMed
    Score: 0.003
  144. Mohideen N, Kavanagh BD, Beyer D, Madhani S, Steinberg ML. Radiation oncology: a perspective on health reform and value-based initiatives. J Oncol Pract. 2014 Jul; 10(4):e212-4.
    View in: PubMed
    Score: 0.003
  145. Qi XS, Liu TX, Liu AK, Newman F, Rabinovitch R, Kavanagh B, Hu YA. Left-sided breast cancer irradiation using rotational and fixed-field radiotherapy. Med Dosim. 2014; 39(3):227-34.
    View in: PubMed
    Score: 0.003
  146. Gan GN, Weickhardt AJ, Scheier B, Doebele RC, Gaspar LE, Kavanagh BD, Camidge DR. Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinib. Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):892-8.
    View in: PubMed
    Score: 0.003
  147. Kavanagh BD, Brizel DM, Leopold KA, Acker JC. Radiation therapy for head and neck cancer in a patient with Takayasu's arteritis. Acta Oncol. 1994; 33(1):73-4.
    View in: PubMed
    Score: 0.003
  148. Jones BL, Gan G, Kavanagh B, Miften M. Effect of endorectal balloon positioning errors on target deformation and dosimetric quality during prostate SBRT. Phys Med Biol. 2013 Nov 21; 58(22):7995-8006.
    View in: PubMed
    Score: 0.003
  149. Altunbas C, Howells C, Proper M, Reddy K, Gan G, DeWitt P, Kavanagh B, Schefter T, Miften M. Evaluation of threshold and gradient based (18)F-fluoro-deoxy-2-glucose hybrid positron emission tomographic image segmentation methods for liver tumor delineation. Pract Radiat Oncol. 2014 Jul-Aug; 4(4):217-25.
    View in: PubMed
    Score: 0.003
  150. Altunbas C, Kavanagh B, Dzingle W, Stuhr K, Gaspar L, Miften M. Dosimetric errors during treatment of centrally located lung tumors with stereotactic body radiation therapy: Monte Carlo evaluation of tissue inhomogeneity corrections. Med Dosim. 2013; 38(4):436-41.
    View in: PubMed
    Score: 0.003
  151. Vinogradskiy Y, Diot Q, Kavanagh B, Schefter T, Gaspar L, Miften M. Spatial and dose-response analysis of fibrotic lung changes after stereotactic body radiation therapy. Med Phys. 2013 Aug; 40(8):081712.
    View in: PubMed
    Score: 0.003
  152. Kavanagh BD, Halperin EC, Nilaver G. Syndrome of inappropriate secretion of antidiuretic hormone in a patient with carcinoma of the nasopharynx. Cancer. 1993 Jul 01; 72(1):299.
    View in: PubMed
    Score: 0.003
  153. Reddy K, Gaspar LE, Kavanagh BD, Waziri A, Damek DM, Ney D, Lillehei KO, Chen C. Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide. J Neurooncol. 2013 Aug; 114(1):111-6.
    View in: PubMed
    Score: 0.003
  154. Amin NP, Miften M, Thornton D, Ryan N, Kavanagh B, Gaspar LE. Effect of induction chemotherapy on estimated risk of radiation pneumonitis in bulky non-small cell lung cancer. Med Dosim. 2013; 38(3):320-6.
    View in: PubMed
    Score: 0.003
  155. Kavanagh BD, Coffey BE, Needham D, Hochmuth RM, Dewhirst MW. The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH, and lactate treatment. Br J Cancer. 1993 Apr; 67(4):734-41.
    View in: PubMed
    Score: 0.003
  156. Weickhardt AJ, Scheier B, Burke JM, Gan G, Lu X, Bunn PA, Aisner DL, Gaspar LE, Kavanagh BD, Doebele RC, Camidge DR. Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer. J Thorac Oncol. 2012 Dec; 7(12):1807-1814.
    View in: PubMed
    Score: 0.003
  157. Hartford AC, Galvin JM, Beyer DC, Eichler TJ, Ibbott GS, Kavanagh B, Schultz CJ, Rosenthal SA. American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for Intensity-modulated Radiation Therapy (IMRT). Am J Clin Oncol. 2012 Dec; 35(6):612-7.
    View in: PubMed
    Score: 0.003
  158. Westerly DC, Schefter TE, Kavanagh BD, Chao E, Lucas D, Flynn RT, Miften M. High-dose MVCT image guidance for stereotactic body radiation therapy. Med Phys. 2012 Aug; 39(8):4812-9.
    View in: PubMed
    Score: 0.003
  159. Howells CC, Stinauer MA, Diot Q, Westerly DC, Schefter TE, Kavanagh BD, Miften M. Normal liver tissue density dose response in patients treated with stereotactic body radiation therapy for liver metastases. Int J Radiat Oncol Biol Phys. 2012 Nov 01; 84(3):e441-6.
    View in: PubMed
    Score: 0.003
  160. Jones BL, Gan G, Diot Q, Kavanagh B, Timmerman RD, Miften M. Dosimetric and deformation effects of image-guided interventions during stereotactic body radiation therapy of the prostate using an endorectal balloon. Med Phys. 2012 Jun; 39(6):3080-8.
    View in: PubMed
    Score: 0.003
  161. Diot Q, Kavanagh B, Schefter T, Gaspar L, Stuhr K, Miften M. Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors. Int J Radiat Oncol Biol Phys. 2012 Nov 15; 84(4):1024-30.
    View in: PubMed
    Score: 0.003
  162. Reddy K, Damek D, Gaspar LE, Ney D, Waziri A, Lillehei K, Stuhr K, Kavanagh BD, Chen C. Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2012 Nov 01; 84(3):655-60.
    View in: PubMed
    Score: 0.003
  163. Kavanagh BD, Halperin EC, Rosenbaum LC, Shannon EM, Nilaver G. Syndrome of inappropriate secretion of antidiuretic hormone in a patient with carcinoma of the nasopharynx. Cancer. 1992 Mar 15; 69(6):1315-9.
    View in: PubMed
    Score: 0.003
  164. H?yer M, Swaminath A, Bydder S, Lock M, M?ndez Romero A, Kavanagh B, Goodman KA, Okunieff P, Dawson LA. Radiotherapy for liver metastases: a review of evidence. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):1047-57.
    View in: PubMed
    Score: 0.003
  165. Kavanagh B, Anscher M, Leopold K, Deutsch M, Gaydica E, Dodge R, Allen K, Allen D, Staub W, Montana G, et al. Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990. Int J Radiat Oncol Biol Phys. 1992; 24(4):633-42.
    View in: PubMed
    Score: 0.003
  166. Diot Q, Kavanagh B, Timmerman R, Miften M. Biological-based optimization and volumetric modulated arc therapy delivery for stereotactic body radiation therapy. Med Phys. 2012 Jan; 39(1):237-45.
    View in: PubMed
    Score: 0.003
  167. Amin NP, Miften M, Kavanagh B, Raben D, Camidge DR, Thornton D, Rochford N, Gaspar LE. Impact of induction chemotherapy on estimated risk of radiation pneumonitis in small cell lung cancer. J Thorac Oncol. 2011 Sep; 6(9):1553-62.
    View in: PubMed
    Score: 0.003
  168. Loo BW, Kavanagh BD, Meyer JL. Motion management and image guidance for thoracic tumor radiotherapy: clinical treatment programs. Front Radiat Ther Oncol. 2011; 43:271-291.
    View in: PubMed
    Score: 0.003
  169. Stinauer MA, Kavanagh BD, Schefter TE, Gonzalez R, Flaig T, Lewis K, Robinson W, Chidel M, Glode M, Raben D. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control. Radiat Oncol. 2011 Apr 08; 6:34.
    View in: PubMed
    Score: 0.003
  170. Kavanagh B. Burkitt's lymphoma. N C Med J. 1991 Apr; 52(4):141.
    View in: PubMed
    Score: 0.003
  171. Chang DT, Swaminath A, Kozak M, Weintraub J, Koong AC, Kim J, Dinniwell R, Brierley J, Kavanagh BD, Dawson LA, Schefter TE. Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer. 2011 Sep 01; 117(17):4060-9.
    View in: PubMed
    Score: 0.003
  172. Heinzerling JH, Kavanagh B, Timmerman RD. Stereotactic ablative radiation therapy for primary lung tumors. Cancer J. 2011 Jan-Feb; 17(1):28-32.
    View in: PubMed
    Score: 0.003
  173. Fields EC, Damek D, Gaspar LE, Liu AK, Kavanagh BD, Waziri A, Lillehei K, Chen C. Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):51-7.
    View in: PubMed
    Score: 0.003
  174. Rusthoven KE, Olsen C, Franklin W, Kleinschmidt-DeMasters BK, Kavanagh BD, Gaspar LE, Lillehei K, Waziri A, Damek DM, Chen C. Favorable prognosis in patients with high-grade glioma with radiation necrosis: the University of Colorado reoperation series. Int J Radiat Oncol Biol Phys. 2011 Sep 01; 81(1):211-7.
    View in: PubMed
    Score: 0.002
  175. Diot Q, Olsen C, Kavanagh B, Raben D, Miften M. Dosimetric effect of online image-guided anatomical interventions for postprostatectomy cancer patients. Int J Radiat Oncol Biol Phys. 2011 Feb 01; 79(2):623-32.
    View in: PubMed
    Score: 0.002
  176. Zhang L, Kavanagh BD, Thorburn AM, Camidge DR. Preclinical and clinical estimates of the basal apoptotic rate of a cancer predict the amount of apoptosis induced by subsequent proapoptotic stimuli. Clin Cancer Res. 2010 Sep 01; 16(17):4478-89.
    View in: PubMed
    Score: 0.002
  177. Dawson LA, Kavanagh BD, Paulino AC, Das SK, Miften M, Li XA, Pan C, Ten Haken RK, Schultheiss TE. Radiation-associated kidney injury. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3 Suppl):S108-15.
    View in: PubMed
    Score: 0.002
  178. Pan CC, Kavanagh BD, Dawson LA, Li XA, Das SK, Miften M, Ten Haken RK. Radiation-associated liver injury. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3 Suppl):S94-100.
    View in: PubMed
    Score: 0.002
  179. Flaig TW, Kondo KL, La Rosa FG, Kavanagh B, Crawford ED. A young woman with multiple kidney lesions. Oncology (Williston Park). 2010 Mar; 24(3):282-6.
    View in: PubMed
    Score: 0.002
  180. Potters L, Gaspar LE, Kavanagh B, Galvin JM, Hartford AC, Hevezi JM, Kupelian PA, Mohiden N, Samuels MA, Timmerman R, Tripuraneni P, Vlachaki MT, Xing L, Rosenthal SA. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT). Int J Radiat Oncol Biol Phys. 2010 Feb 01; 76(2):319-25.
    View in: PubMed
    Score: 0.002
  181. Potters L, Kavanagh B, Galvin JM, Hevezi JM, Janjan NA, Larson DA, Mehta MP, Ryu S, Steinberg M, Timmerman R, Welsh JS, Rosenthal SA. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2010 Feb 01; 76(2):326-32.
    View in: PubMed
    Score: 0.002
  182. Diot Q, Olsen C, Kavanagh B, Raben D, Miften M. Impact of anatomical interventions on the localization of post-prostatectomy cancer patients. Med Phys. 2010 Feb; 37(2):629-37.
    View in: PubMed
    Score: 0.002
  183. Pugh TJ, Ballonoff A, Rusthoven KE, McCammon R, Kavanagh B, Newman F, Rabinovitch R. Cardiac mortality in patients with stage I and II diffuse large B-cell lymphoma treated with and without radiation: a surveillance, epidemiology, and end-results analysis. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3):845-9.
    View in: PubMed
    Score: 0.002
  184. Dunlap NE, Cai J, Biedermann GB, Yang W, Benedict SH, Sheng K, Schefter TE, Kavanagh BD, Larner JM. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3):796-801.
    View in: PubMed
    Score: 0.002
  185. McCammon R, Rusthoven KE, Kavanagh B, Newell S, Newman F, Raben D. Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2009 Oct 01; 75(2):413-20.
    View in: PubMed
    Score: 0.002
  186. Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, Pugh TJ, Kane M, Gaspar LE, Schefter TE. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol. 2009 Apr 01; 27(10):1579-84.
    View in: PubMed
    Score: 0.002
  187. Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol. 2009 Apr 01; 27(10):1572-8.
    View in: PubMed
    Score: 0.002
  188. Fong L, Kwek SS, O'Brien S, Kavanagh B, McNeel DG, Weinberg V, Lin AM, Rosenberg J, Ryan CJ, Rini BI, Small EJ. Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF. Cancer Res. 2009 Jan 15; 69(2):609-15.
    View in: PubMed
    Score: 0.002
  189. Hartford AC, Palisca MG, Eichler TJ, Beyer DC, Devineni VR, Ibbott GS, Kavanagh B, Kent JS, Rosenthal SA, Schultz CJ, Tripuraneni P, Gaspar LE. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT). Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):9-14.
    View in: PubMed
    Score: 0.002
  190. Rusthoven KE, Hammerman SF, Kavanagh BD, Birtwhistle MJ, Stares M, Camidge DR. Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis. Acta Oncol. 2009; 48(4):578-83.
    View in: PubMed
    Score: 0.002
  191. Schwer AL, Kavanagh BD, McCammon R, Gaspar LE, Kleinschmidt-De Masters BK, Stuhr K, Chen C. Radiographic and histopathologic observations after combined EGFR inhibition and hypofractionated stereotactic radiosurgery in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 2009 Apr 01; 73(5):1352-7.
    View in: PubMed
    Score: 0.002
  192. Olsen CC, Welsh J, Kavanagh BD, Franklin W, McCarter M, Cardenes HR, Gaspar LE, Schefter TE. Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2009 Apr 01; 73(5):1414-24.
    View in: PubMed
    Score: 0.002
  193. Ballonoff A, Kavanagh B, McCarter M, Kane M, Pearlman N, Nash R, Shah RJ, Raben D, Schefter TE. Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial. Am J Clin Oncol. 2008 Jun; 31(3):264-70.
    View in: PubMed
    Score: 0.002
  194. Ballonoff A, Rusthoven KE, Schwer A, McCammon R, Kavanagh B, Bassetti M, Newman F, Rabinovitch R. Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis. Int J Radiat Oncol Biol Phys. 2008 Dec 01; 72(5):1465-71.
    View in: PubMed
    Score: 0.002
  195. Solberg TD, Kavanagh BD, Medin PM. Stereotactic body radiation therapy: a new paradigm in radiotherapy management of cancer. J Am Coll Radiol. 2008 May; 5(5):673-7.
    View in: PubMed
    Score: 0.002
  196. Kudchadkar R, Gonzalez R, Lewis K, Treichel K, Hammerman S, Robinson W, Fitzpatrick J, Gonzalez R, Kavanagh B, Rusthoven K. A case of Merkel cell carcinoma. Oncology (Williston Park). 2008 Mar; 22(3):322-8.
    View in: PubMed
    Score: 0.002
  197. Hou Y, Kavanagh B, Fong L. Distinct CD8+ T cell repertoires primed with agonist and native peptides derived from a tumor-associated antigen. J Immunol. 2008 Feb 01; 180(3):1526-34.
    View in: PubMed
    Score: 0.002
  198. Ballonoff A, Kavanagh B, Nash R, Drabkin H, Trotter J, Costa L, Rabinovitch R. Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: statistical analysis of all published cases and literature review. Acta Oncol. 2008; 47(5):962-70.
    View in: PubMed
    Score: 0.002
  199. Schwer AL, Damek DM, Kavanagh BD, Gaspar LE, Lillehei K, Stuhr K, Chen C. A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 2008 Mar 15; 70(4):993-1001.
    View in: PubMed
    Score: 0.002
  200. Flaig T, Crawford ED, Kavanagh B, Lucia S, La Rosa F, Barqawi A, Crighton F, Glod? LM. Prostate cancer in a man with multiple previous cancers. Oncology (Williston Park). 2007 Apr; 21(5):611-4.
    View in: PubMed
    Score: 0.002
  201. Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol. 2007 Mar 10; 25(8):947-52.
    View in: PubMed
    Score: 0.002
  202. Timmerman R, Abdulrahman R, Kavanagh BD, Meyer JL. Lung cancer: a model for implementing stereotactic body radiation therapy into practice. Front Radiat Ther Oncol. 2007; 40:368-385.
    View in: PubMed
    Score: 0.002
  203. Baisden JM, Reish AG, Sheng K, Larner JM, Kavanagh BD, Read PW. Dose as a function of liver volume and planning target volume in helical tomotherapy, intensity-modulated radiation therapy-based stereotactic body radiation therapy for hepatic metastasis. Int J Radiat Oncol Biol Phys. 2006 Oct 01; 66(2):620-5.
    View in: PubMed
    Score: 0.002
  204. Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys. 2005 Aug 01; 62(5):1371-8.
    View in: PubMed
    Score: 0.002
  205. Song DY, Kavanagh BD, Benedict SH, Schefter T. Stereotactic body radiation therapy. Rationale, techniques, applications, and optimization. Oncology (Williston Park). 2004 Oct; 18(11):1419-30; discussion 1430, 1432, 1435-6.
    View in: PubMed
    Score: 0.002
  206. Arthur DW, Koo D, Zwicker RD, Tong S, Bear HD, Kaplan BJ, Kavanagh BD, Warwicke LA, Holdford D, Amir C, Archer KJ, Schmidt-Ullrich RK. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys. 2003 Jul 01; 56(3):681-9.
    View in: PubMed
    Score: 0.002
  207. Manning MA, Wu Q, Cardinale RM, Mohan R, Lauve AD, Kavanagh BD, Morris MM, Schmidt-Ullrich RK. The effect of setup uncertainty on normal tissue sparing with IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001 Dec 01; 51(5):1400-9.
    View in: PubMed
    Score: 0.001
  208. Manning MA, Cardinale RM, Schmidt-Ullrich RK, Kavanagh BD, Wornom IL, Broaddus WC. Extracorporeal irradiation of tumorous calvaria. Case report. J Neurosurg. 2000 Sep; 93(3):494-7.
    View in: PubMed
    Score: 0.001
  209. Manning MA, Cardinale RM, Benedict SH, Kavanagh BD, Zwicker RD, Amir C, Broaddus WC. Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases. Int J Radiat Oncol Biol Phys. 2000 Jun 01; 47(3):603-8.
    View in: PubMed
    Score: 0.001
  210. Cardinale RM, Wu Q, Benedict SH, Kavanagh BD, Bump E, Mohan R. Determining the optimal block margin on the planning target volume for extracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys. 1999 Sep 01; 45(2):515-20.
    View in: PubMed
    Score: 0.001
  211. Arthur DW, Kavanagh BD, Schmidt-Ullrich RK. Re: Hsu et al. 1998; 40(2):405-410. Int J Radiat Oncol Biol Phys. 1998 Dec 01; 42(5):1177-8.
    View in: PubMed
    Score: 0.001
  212. Schmidt-Ullrich RK, Mikkelsen RB, Dent P, Todd DG, Valerie K, Kavanagh BD, Contessa JN, Rorrer WK, Chen PB. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene. 1997 Sep 04; 15(10):1191-7.
    View in: PubMed
    Score: 0.001
  213. Lutz ST, Huang DT, Ferguson CL, Kavanagh BD, Tercilla OF, Lu J. A retrospective quality of life analysis using the Lung Cancer Symptom Scale in patients treated with palliative radiotherapy for advanced nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys. 1997 Jan 01; 37(1):117-22.
    View in: PubMed
    Score: 0.001
  214. Zwicker RD, Atari NA, Kavanagh BD, Gieschen HL, Arnfield MR, Khandelwal SR, Schmidt-Ullrich RK. Clinical use of a digital simulator for rapid setup verification in high dose rate brachytherapy. Int J Radiat Oncol Biol Phys. 1995 Nov 01; 33(4):931-6.
    View in: PubMed
    Score: 0.001
  215. Arthur D, Kaufman N, Schmidt-Ullrich R, Kavanagh B, Simpson P, Hill M, Ali M. Heuristically derived tumor burden score as a prognostic factor for stage IIIB carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 1995 Feb 15; 31(4):743-51.
    View in: PubMed
    Score: 0.001
  216. Mak AC, Rich TA, Schultheiss TE, Kavanagh B, Ota DM, Romsdahl MM. Late complications of postoperative radiation therapy for cancer of the rectum and rectosigmoid. Int J Radiat Oncol Biol Phys. 1994 Feb 01; 28(3):597-603.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)